Tyme Technologies Inc. (TYME) Accused of Distorting Data According to the complaint, Tyme is developing SM-88, a combination therapy based on dysfunctional metyrosine derivatives for metastatic pancreatic cancer and biomarker-recurrent

22nd Century Group, Inc. (XXII) Accused of Manipulating Its Stock Price According to the complaint, since 2016, while 22nd Century Group, Inc. (XXII) filed 10Ks that noted that its stock

Uxin Limited (UXIN) Accused of Inflating its IPO Price According to the complaint, Uxin Limited (UXIN) held its IPO in June 2018, and generated over $205 million in proceeds based

U.S. Court of Appeals Denies RH’s Petition to Appeal Class Certification in Securities Class Action In an order filed January 24, 2019, the U.S. Court of Appeals for the Ninth Circuit

Lexicon Pharmaceuticals, Inc. (LXRX) Accused of Issuing Materially False Statements According to the complaint, Lexicon Pharmaceuticals, Inc. (LXRX) entered into a collaboration and license agreement with Sanofi for Sotagliflozin, also

Aerohive Networks, Inc. (HIVE) Intentionally Overstated its Financials to the Detriment of Shareholders According a federal securities class action complaint filed by investors, Aerohive Networks, Inc. publicly made false and

Investigating the Officers and Directors of Super Micro Computer, Inc. (SMCI) After Report Alleging Chinese Hacking Crashes Stock Price October 5, 2018 (San Diego, CA & San Jose, CA) –

Robbins LLP Investigates Maxar Technologies Inc. (MAXR) for Hiding Problems With Its Satellite Purchasers of Maxar Technologies Inc. (NYSE: MAXR) filed a class action against the company for alleged violations

Maxar Technologies Inc. (MAXR) Accused of Inflating the Value of its Intangible Assets According to the complaint, in October 2017, MacDonald purchased DigitalGlobe and acquired DigitalGlobe’s satellites, including the WorldView-4